Considerations for Future SARS-CoV-2 Vaccines: A Private Sector Perspective

May 12, 2020

Several vaccine candidates are being tested to help address the ongoing COVID-19 pandemic. Uncertainty remains about key epidemiologic factors to characterize the disease, including true infection rate, proportion of symptomatic cases, and potential for re-infection. As the virus spreads and data continue to develop, the potential role of vaccination will continue to evolve. This presentation will describe some of the data needed to inform vaccination strategies, as well as guide the development and manufacture of future vaccines. Partnerships between public, private, and academic research groups will be essential to ensure rapid and fair deployment of future vaccines, define a research agenda, and balance supply and demand in the early phases of vaccine availability.

Registration is open here.

You May Also Like

Digital Transformation Journey of the National Immunisation Information System in Vietnam

The Vietnam National Immunisation Information System (NIIS) has proven to stand the test of time and adversity throughout the 12-year journey of digital transformation from the paper-based system. The system journey was certainly not without difficulties, challenges, and even failures, and PATH is honored to accompany Vietnam National Expanded Program on Immunisation (NEPI) along this … Continued

EIR or IIS – How to Select the Best Digital Immunisation System for your Country Context

This webinar series presents the leading Electronic Immunization Registries (EIR) and Immunization Information Systems (IIS) software and service options that are currently deployed in the field. It also explores how to select, procure, and implement a robust EIR/IIS. ​This includes examining the different functionalities in order to aid the selection of the right system to … Continued